Literature DB >> 12452369

Chronic renal failure-induced changes in serum and urine bile acid profiles.

F Jimenez1, M J Monte, M Y El-Mir, M J Pascual, J J G Marin.   

Abstract

Although the kidney is believed to play a minor role in bile acid (BA) excretion, chronic renal failure (CRF) has been reported to be accompanied by alterations in the BA balance. The aim of the present work was to evaluate the changes in BA serum concentrations and renal excretion in patients with different stage of CRF or after kidney transplantation and to elucidate whether these might play a role in the development of pruritus, a common symptom in this disease. This study was carried out on 125 patients. None of them had a history or signs of hepatobiliary malfunction. They belonged either to a control group (N = 31) or to one of the three following CRF groups: patients maintained only on a low-protein diet (diet group, N = 23); the same, together with periodic sessions of hemodialysis (dialysis group, N = 42); and patients who had undergone a kidney transplant more than 1 and less than 2 years before (transplanted group, N = 29). Serum and urine BA concentrations were assayed by gas chromatography-mass spectrometry. Pruritus was quantified by means of a questionnaire answered at the time of sample collection. A marked hypercholanemia together with a reduction in BA output into urine and profound alterations in the profiles of these compounds in both serum and urine in patients with CRF were observed. The levels of total BAs in serum, but not the proportions of molecular species, were corrected by hemodialysis. By contrast, kidney transplant reversed BA serum patterns to normality but, due to immunosuppressive therapy with cyclosporin A, total serum BA concentrations were consistently elevated in this group. Pruritus was more frequent in patients with impaired kidney function and hypercholanemia, although no significant correlation between the degree of this symptom and the magnitude of the serum concentrations of total or individual BAs were found. By contrast, in spite of hypercholanemia, once renal function had been restored by kidney transplantation, none of the patients suffered from pruritus. These results suggest that the kidney plays an important role in determining the serum BA pool size and composition and that hypercholanemia may be a contributing factor, but not the only one, determining the development of pruritus in patients with CRF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452369     DOI: 10.1023/a:1020575001944

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Effective treatment of cyclosporine-induced cholestasis in heart-transplanted patients treated with ursodeoxycholic acid.

Authors:  B Kallinowski; L Theilmann; R Zimmermann; E Gams; B Kommerell; A Stiehl
Journal:  Transplantation       Date:  1991-05       Impact factor: 4.939

2.  Urinary excretion of bile acids in patients with obstructive jaundice and hepatocellular disease.

Authors:  J A Gregg
Journal:  Am J Clin Pathol       Date:  1968-03       Impact factor: 2.493

3.  Bacterial populations of the small intestine in uremia.

Authors:  M L Simenhoff; J J Saukkonen; J F Burke; L G Wesson; R W Schaedler; S J Gordon
Journal:  Nephron       Date:  1978       Impact factor: 2.847

4.  Rifampin relieves pruritus in children with cholestatic liver disease.

Authors:  H A Cynamon; J M Andres; R P Iafrate
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

5.  Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.

Authors:  G P van Berge Henegouwen; K H Brandt; H Eyssen; G Parmentier
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

6.  Abnormal intestinal bile acid distribution in azotaemic man: a possible role in the pathogenesis of uraemic diarrhoea.

Authors:  S J Gordon; L J Miller; L J Haeffner; M D Kinsey; O D Kowlessar
Journal:  Gut       Date:  1976-01       Impact factor: 23.059

7.  Identification of the bile acid binding proteins in human serum by photoaffinity labeling.

Authors:  W Kramer
Journal:  Biochim Biophys Acta       Date:  1995-08-03

8.  Regulation of cholesterol 7 alpha-hydroxylase mRNA and transcriptional activity by taurocholate and cholesterol in the chronic biliary diverted rat.

Authors:  W M Pandak; Y C Li; J Y Chiang; E J Studer; E C Gurley; D M Heuman; Z R Vlahcevic; P B Hylemon
Journal:  J Biol Chem       Date:  1991-02-25       Impact factor: 5.157

9.  [An increase in bile acids in the serum of patients with chronic kidney failure].

Authors:  P L Balestri; R Berni; A Cupisti; R Giordani
Journal:  Minerva Med       Date:  1995-05       Impact factor: 4.806

10.  Bile acid synthesis from cholesterol: regulatory and auxiliary pathways.

Authors:  N B Javitt
Journal:  FASEB J       Date:  1994-12       Impact factor: 5.191

View more
  15 in total

1.  Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.

Authors:  Anna Jovanovich; Tamara Isakova; Geoffrey Block; Jason Stubbs; Gerard Smits; Michel Chonchol; Makoto Miyazaki
Journal:  Am J Kidney Dis       Date:  2017-08-09       Impact factor: 8.860

2.  The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis.

Authors:  Kevin T Bush; Wei Wu; Christina Lun; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2017-08-01       Impact factor: 5.157

3.  Mechanism underlying an elevated serum bile acid level in chronic renal failure patients.

Authors:  Lei Chu; Kangkang Zhang; Yingying Zhang; Xunbo Jin; Huaxin Jiang
Journal:  Int Urol Nephrol       Date:  2014-12-25       Impact factor: 2.370

4.  Bile Acids Are Important Contributors to AKI Associated with Liver Disease: PRO.

Authors:  Peter Fickert; Alexander R Rosenkranz
Journal:  Kidney360       Date:  2021-05-03

Review 5.  Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease.

Authors:  Judy Baek; Chenchen He; Farsad Afshinnia; George Michailidis; Subramaniam Pennathur
Journal:  Nat Rev Nephrol       Date:  2021-10-06       Impact factor: 42.439

Review 6.  Pathogenesis and treatment of pruritus in cholestasis.

Authors:  Andreas E Kremer; Ulrich Beuers; Ronald P J Oude-Elferink; Thomas Pusl
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 7.  The role of chronic kidney disease-associated dysbiosis in cardiovascular disease.

Authors:  Mark A Bryniarski; Fares Hamarneh; Rabi Yacoub
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-25

Review 8.  Microbiome and Cardiovascular Disease in CKD.

Authors:  Anna Jovanovich; Tamara Isakova; Jason Stubbs
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-09       Impact factor: 8.237

9.  Fecal Metabolomics Reveals Distinct Profiles of Kidney Transplant Recipients and Healthy Controls.

Authors:  Soumaya Kouidhi; Oumaima Zidi; Muhanad Alhujaily; Nessrine Souai; Amor Mosbah; Tareg M Belali; Kais Ghedira; Imene El Kossai; Jamelddine El Manaa; Wissem Mnif; Ameur Cherif
Journal:  Diagnostics (Basel)       Date:  2021-04-29

10.  Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKD.

Authors:  Cassandra Kimber; Shiqin Zhang; Cassandra Johnson; Raymond E West; Alexander J Prokopienko; Jonathan D Mahnken; Alan S Yu; Andrew N Hoofnagle; Diana Ir; Charles E Robertson; Makoto Miyazaki; Michel Chonchol; Anna Jovanovich; Bryan Kestenbaum; Daniel N Frank; Thomas D Nolin; Jason R Stubbs
Journal:  Kidney360       Date:  2020-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.